iBio, Inc.IBIONYSE
Loading
Year-over-year gross profit growth rate
Percentile
P38
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -27.51% |
| Q3 2025 | -194.50% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 100.00% |
| Q3 2023 | -545.16% |
| Q2 2023 | 89.01% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | -97.44% |
| Q1 2022 | 274.25% |
| Q4 2021 | -42.29% |
| Q3 2021 | -338.82% |
| Q2 2021 | 11.76% |
| Q1 2021 | -44.94% |
| Q4 2020 | 63.04% |
| Q3 2020 | 17.44% |
| Q2 2020 | 2480.00% |
| Q1 2020 | -96.82% |
| Q4 2019 | 190.74% |
| Q3 2019 | -86.42% |
| Q2 2019 | 50.85% |
| Q1 2019 | -19.05% |
| Q4 2018 | 1346.67% |
| Q3 2018 | -50.55% |
| Q2 2018 | 16.67% |
| Q1 2018 | -49.02% |
| Q4 2017 | 25.41% |
| Q3 2017 | -17.01% |
| Q2 2017 | 297.30% |
| Q1 2017 | -50.67% |
| Q4 2016 | -44.44% |
| Q3 2016 | -50.91% |
| Q2 2016 | -27.44% |
| Q1 2016 | 182.84% |